Aktis Oncology, Inc.
Disclosed SEC business address
17 DRYDOCK AVENUE, SUITE #17-401, BOSTON, MA, 02210
Aktis Oncology, Inc. (ticker AKTS, CIK 0002035832) is tracked by Global Barry from its public SEC filings and disclosures. Disclosed industry classification: Pharmaceutical Preparations (SIC 2834). Disclosed business address country: United States. Every item is grounded on the cited public source — no figures are fabricated.
You've reached this month's free company deep views
The public preview above stays free and available. To open the deeper, source-linked evidence detail — and the full in-app workspace — sign up free or upgrade your plan. Higher plans include more (or unlimited) deep views each month.
Bringing your own AI key (BYOK) raises only your AI analysis cap — it does not raise the company deep-view cap.
Sources
- U.S. Securities and Exchange Commission, EDGAR · XBRL company facts · retrieved 2026-10-19T08:52:55.582941+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-10-31T05:50:59.175845+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-10-31T05:51:03.152217+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-10-31T05:50:53.003232+00:00
Grounded on public SEC filings and disclosures with explicit evidence tiers and citations. This page is informational only and is not investment advice. No figures are fabricated; unavailable data is shown as unavailable.